89. Green D, Lechner K. A survey of 215 non-hemophilic patients
with inhibitors to factor VIII. Thromb Haemost 1981;45:200– 3.
90. Collins PW, Hirsch S, Baglin TP, et al. Acquired hemophilia A
in the United Kingdom: A 2 year national surveillance study by
the United Kingdom Haemophilia Center Doctors’ Organisation. Blood 2007;109:1870– 7.
91. Kessler CM, Ludlam CA. The treatment of acquired factor
VIII inhibitors: Worldwide experience with porcine factor
VIII concentrate. International Acquired Hemophilia Study
Group. Semin Hematol 1993; 30(Suppl. 1): 22–7.
92. Green D, Rademaker AW, Briet E. A prospective, randomized
trial of prednisone and cyclophosphamide in the treatment
of patients with factor VIII autoantibodies. Thromb Haemost
93. Stasi R, Brunetti M, Stipa E, Amadori S. Selective B-cell depletion with rituximab for the treatment of patients with acquired
hemophilia. Blood 2004;103:4424–8.
94. Franchini M. Rituximab in the treatment of adult acquired
hemophilia A: a systematic review. Crit Rev Oncol Hematol